Public reporting of outcomes in radiation oncology: the National Prostate Cancer Audit

Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study

“…From a wider structural perspective, the study highlights the importance of ensuring adequate funding is available to develop high-quality outcomes research programs to inform policy and practice. We found that 54% of RWD studies included in our evaluation did not receive funding [ 18 ]. However, industry-funded studies were more likely to be of better quality than other studies.…”

Health service planning to assess the expected impact of centralising specialist cancer services on travel times, equity, and outcomes: a national population-based modelling study

“…However, the impact on other clinical outcome measures can easily be considered if there is evidence for substantial between-hospital differences, including margin status, rates of treatment-related adverse events, or relapse rates. 34 In the NHS, information about mortality is published for bowel and oesophageal cancer surgery, and our model could include this information to assess the impact of centralisation on these outcomes as an alternative or in addition to readmission rates. 27,35 With respect to the implications of centralisation, other areas that can be included in future development of the model are the use of service delivery costs, such as with diagnosis-related group tariffs, to understand the economic consequences of centralisation as patients are reallocated.…”

Quality indicators for radiation oncology

“…This data linkage has allowed the lung cancer audit to publish on underuse of concurrent chemoradiation for stage III NSCLC and inequality of access to SABR for early stage lung cancer 30,31 . Most recently the prostate audit combined PRO and administrative data for lower GI procedures two years after prostate RT 32 …”

“…30,31 Most recently the prostate audit combined PRO and administrative data for lower GI procedures two years after prostate RT. 32 In the USA, the Veteran Affairs Radiation Oncology Quality Surveillance programme based on the Q-RRO methodology has successfully collected and reported retrospectively on data to measure quality and patterns of care for prostate and lung cancer collected from hospital electronic medical records in addition to radiation treatment planning and management systems. 33,34 Patterns of care have also been reported directly by Q-RRO and retrospective analysis of the National Cancer Database.…”